Hilchie AL, Sharon AJ, Haney EF, Hoskin DW, Bally MB, Franco OL, Corcoran JA, Hancock RE (2016) Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma
24 weeks ~40 syringes Two injections per week from Week 9 onward
Four DoD Components will participate in the 2014.3 Solicitation: The Department of the Army, The Department of the Navy, Defense Advanced Research Projects Agency (DARPA), and Defense Threat Reduction Agency (DTRA), and U.S
Emerging research further points to its anti-aging effects through collagen synthesis, as well as analgesic benefits [37, 38]
Following oral administration, the drug must be absorbed across the walls of the GI tract and then must escape metabolism as it passes through the liver, in order to reach the systemic circulation